Stem Cells International / 2019 / Article / Fig 4

Research Article

Mesenchymal Stem Cells Alleviate DHEA-Induced Polycystic Ovary Syndrome (PCOS) by Inhibiting Inflammation in Mice

Figure 4

hUC-MSC treatment affects innate immunity cell compartments in PCOS mice. Flow cytometry results of innate immunity cells in the peripheral blood and spleen. (a) The percentage of peripheral and splenic neutrophils (Ly6G+CD11b+). (b) The percentage of peripheral and splenic macrophages (F4/80+). (c) The percentage of peripheral and splenic M1 macrophages (CD11c+). (d) The percentage of peripheral and splenic M2 macrophages (CD206+). (e) Quantitative RT-PCR analysis of the expression of F4/80 in the ovaries and uterus of mice. -10 per group. Values are expressed as the . and .
(a)
(b)
(c)
(d)
(e)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.